Figure 1A), recent studies highlight complementary in situ strategies
Moreover, their optical characteristics for imaging purposes can help the clinicians know the dispersion of the nanoparticles and the effectiveness of the treatments
This can include alternating periods that are heavy and light, spotting or unpredictable shorter and longer cycles
Long-term cardiovascular outcome studies are still underway, but interim data from trials like SUSTAIN-6 (semaglutide in type 2 diabetes) and SUMMIT (semaglutide in obesity without diabetes) showed sustained blood pressure benefits over months and years of treatment
Acute treatment of diet-induced obese mice with labelled semaglutide has been shown to allow the drug to access circumventricular organs that lack a substantial blood brain barrier, including the area postrema (AP), median eminence (ME), vascular organ of the lamina terminalis (OV), and subfornical organ (SFO) ( Figure 3 )